miR-765 induces angiogenesis by inhibiting dipeptidyl peptidase 4 and increasing fibroblast growth factor 2
BBA Advances · 2026 · 9 · 100193
DOI: 10.1016/j.bbadva.2026.100193 ↗Kurz gefasst
Fachartikel in der Zeitschrift BBA Advances, 2026. Verfasst von Koji Ueno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Yamaguchi University.
Abstract (Originalsprache)
Given that extracellular vesicles (EVs) secreted from stem cells contain angiogenic microRNAs (miRNAs), these EVs show equivalent angiogenic therapeutic effect to cell transplantation. This study aimed to identify the angiogenic miRNAs from several miRNAs involved in EVs secreted from stem cells. In human dental pulp stem cells (hDPSCs) under hypoxic culture, vascular endothelial growth factor (VEGF) involved in EVs increased. We hypothesized that angiogenic miRNAs increase in EVs that are secreted from hDPSCs under hypoxic culture compared with those under normoxic culture. In the first screening, the expression levels of miRNAs involved in EVs that were secreted from hDPSCs cultured under hypoxic and normoxic conditions were analyzed using miRNA array. In the second screening, 12 miRNAs were individually involved in EVs, and the growth of human aortic endothelial cells was assayed. In the third screening, miRNA-encapsulated EVs were injected in BALB/c mouse hindlimb ischemia model, followed by angiogenesis evaluation by blood flow analysis. Results showed that miR-765 is an angiogenic miRNA, targeting the 3' untranslated region of dipeptidyl peptidase 4 (DPP4) and upregulating fibroblast growth factor 2 (FGF2) in vitro and in vivo. In conclusion, as an angiogenesis mechanism, miR-765 increased FGF2 expression levels by inhibiting DPP4.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.
- Division of Advanced Cell Therapy, Research Institute for Cell Design Medical Science, Yamaguchi University, Ube, Yamaguchi, Japan.
Förderung
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
- Yamaguchi University
Zitieren
APA
Ueno, K., Kurazumi, H., Murakami, J., Mizoguchi, T., Suzuki, R., Tanaka, T., & Hamano, K. (2026). miR-765 induces angiogenesis by inhibiting dipeptidyl peptidase 4 and increasing fibroblast growth factor 2. BBA Advances, 9, 100193. https://doi.org/10.1016/j.bbadva.2026.100193
Vancouver
Ueno K, Kurazumi H, Murakami J, Mizoguchi T, Suzuki R, Tanaka T, et al. miR-765 induces angiogenesis by inhibiting dipeptidyl peptidase 4 and increasing fibroblast growth factor 2. BBA Advances. 2026;9:100193. doi:10.1016/j.bbadva.2026.100193
BibTeX
@article{Ueno2026,
author = {Ueno, Koji and Kurazumi, Hiroshi and Murakami, Junichi and Mizoguchi, Takahiro and Suzuki, Ryo and Tanaka, Toshiki and Hamano, Kimikazu},
title = {miR-765 induces angiogenesis by inhibiting dipeptidyl peptidase 4 and increasing fibroblast growth factor 2},
journal = {BBA Advances},
year = {2026},
volume = {9},
pages = {100193},
doi = {10.1016/j.bbadva.2026.100193}
}
EUVIMED